tirzepatide fda indications approves new version of diabetes drug Mounjaro to be sold for weight loss FDA says shortage of GLP-1

Important Note GLP3 Planner is an educational tool for visualizing compound pharmacokinetics

This is an autoimmune condition in which the body begins to attack its own cells, specifically those of hair follicles

Last month (May 2025), Novo announced that the US Food and Drug Administration (FDA) accepted its new drug application (NDA) submission for an investigational once-daily oral formulation of Wegovy (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease

Blood in Urine on Saxenda: Causes & When to Act Saxenda (liraglutide 3.0 mg) is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with comorbidities

ggplot2: Elegant Graphics for Data Analysis Vol